With over a decade of experience specializing in weight management, she champions personalized, sustainable, fun, and evidence-based nutrition solutions and behavior change coaching for patients on GLP-1 anti-obesity medications
1,4 Hyperglycemia, dyslipidemia, and insulin resistance activate various metabolic pathways, resulting in oxidative stress, mitochondrial dysfunction, inflammation, and microvascular damage, culminating in neuronal injury, Schwann cell damage, and myelin sheath degeneration
& Rotkvic, I
The goal shifts from rapid return to activity toward sustained symptom control and slowing disease progression
GLP-1 drugs may result in better outcomes for cancer patients, study claims GLP-1 drugs, such as Ozempic and Wegovy, may slow down the spread of obesity-related cancers, according to researchers Bookmark CommentsGo to comments GLP-1 drugs may result in better outcomes for cancer patients, a new study has claimed